Medtronic Bridge
This article was originally published in The Gray Sheet
Executive Summary
Balloon-expandable peripheral stent gains FDA go-ahead for renal vessels following sub-optimal balloon angioplasty based on the 188-patient SOAR registry. The data showed that Bridge use is associated with a 16.8% restenosis rate 12 months post-procedure, compared to historic rates of 26-48%. The new indication supplements the device's 1998 approval for biliary procedures...